Summary of Research: Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trials (the ENHANCE Trials)

Duong N, Lee JY, Peprah Y, Brown T, Linder JA, Doctor JN, Meeker D, Fox CR, Goldstein NJ, Persell SD, Petito LC. Changing Clinician Behavior[...]

Benjamin LN, Núñez ER, Chen L, Motwani Y, Yuan A, Vangala S, Slatore CG, Wiener RS, Elashoff DA, Yano EM, Washington DL, Mangione CM. Centralization[...]

Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB. Methylation[...]